ACUTE CARDIAC TOXICITY IN PATIENTS AFTER DOXORUBICIN TREATMENT AND THE EFFECT OF COMBINED TOCOPHEROL AND NIFEDIPINE PRETREATMENT

被引：25

作者：

LENZHOFER, R ^{[1
]}

GANZINGER, U ^{[1
]}

RAMEIS, H ^{[1
]}

MOSER, K ^{[1
]}

机构：

[1] VIENNA UNIV,MED 1 KLIN,A-1090 VIENNA,AUSTRIA

来源：

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 1983年 / 106卷 / 02期

关键词：

D O I：

10.1007/BF00395393

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：143 / 147

页数：5

共 28 条

[1]

BENJAMIN RS, 1982, ANN INTERN MED, V96, P133

[2] DOSE-EFFECT AND STRUCTURE-FUNCTION-RELATIONSHIPS IN DOXORUBICIN CARDIOMYOPATHY [J].

BRISTOW, MR ;

MASON, JW ;

BILLINGHAM, ME ;

DANIELS, JR .

AMERICAN HEART JOURNAL, 1981, 102 (04) :709-718

[3] ADRIAMYCIN-CARDIOMYOPATHY INDUCED BY AN INCREMENT OF [CA2+] [J].

BUHNER, R ;

BIEDERT, S ;

MIURA, D .

KLINISCHE WOCHENSCHRIFT, 1980, 58 (14) :747-748

[4]

CHAN KK, 1978, CANCER TREAT REP, V62, P1161

[5] EVALUATION OF CARDIAC ACTIVITY AND PHARMACOKINETIC ANALYSIS OF ADRIAMYCIN-H-3 IN PATIENTS PRETREATED WITH BETA-METHYLDIGOXIN [J].

DIFRONZO, G ;

BERTUZZI, A ;

RONCHI, E ;

VILLANI, FP ;

RONCHETTI, L .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1979, 2 (03) :169-173

[6]

DOMAE N, 1981, CANCER TREAT REP, V65, P79

[7] THE PHARMACOKINETICS OF ADRIAMYCIN AND ADRIAMYCIN-METABOLITES [J].

EHNINGER, G ;

STOCKER, HJ ;

PROKSCH, B ;

WILMS, K .

KLINISCHE WOCHENSCHRIFT, 1980, 58 (18) :927-934

[8] SPECIFIC PHARMACOLOGY OF CALCIUM IN MYOCARDIUM, CARDIAC-PACEMAKERS, AND VASCULAR SMOOTH-MUSCLE [J].

FLECKENSTEIN, A .

ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1977, 17 :149-166

[9] IGPHARM - INTERACTIVE GRAPHIC PACKAGE FOR PHARMACOKINETIC ANALYSIS [J].

GOMENI, C ;

GOMENI, R .

COMPUTERS AND BIOMEDICAL RESEARCH, 1978, 11 (04) :345-361

[10]

GOSALVEZ M, 1979, CANCER RES, V39, P257

← 1 2 3 →